VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

MIRA Pharmaceuticals, Inc. (MIRA) Total Return Calculator with Dividends Reinvested

MIRA Pharmaceuticals, Inc.

Popular:

The total return for MIRA Pharmaceuticals, Inc. (MIRA) stock is -12.82% over the past 12 months. So far it's down 31.54% this year. The 5-year total return is -84.11%, meaning $10,000 invested in MIRA stock 5 years ago would be worth $1,589 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in MIRA 1 year ago, it would be worth $8,333 today — you'd have lost $1,667.

With Dividends Reinvested$8,333-16.67%

Price Only (No DRIP)$8,333-16.67%

Period2025-05-06 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in MIRA

1Y$8,718-$1,282 (-12.8%)-12.8% CAGR

3Y$1,589-$8,411 (-84.1%)-45.8% CAGR

5Y$1,589-$8,411 (-84.1%)-30.8% CAGR

10Y$1,589-$8,411 (-84.1%)-16.8% CAGR

15Y$1,589-$8,411 (-84.1%)-11.5% CAGR

20Y$1,589-$8,411 (-84.1%)-8.8% CAGR

30Y$1,589-$8,411 (-84.1%)-5.9% CAGR

MIRA Pharmaceuticals, Inc. did not pay dividends during this period. Total return = price return.

Loading MIRA total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-31.54%	—	-32.89%	+1.34 pp	$6,846
1Y	-12.82%	-12.82%	-16.67%	+3.85 pp	$8,718
3Y	-84.11%	-45.84%	-84.42%	+0.31 pp	$1,589
5Y	-84.11%	-30.78%	-84.42%	+0.31 pp	$1,589
10Y	-84.11%	-16.80%	-84.42%	+0.31 pp	$1,589
15Y	-84.11%	-11.54%	-84.42%	+0.31 pp	$1,589
20Y	-84.11%	-8.79%	-84.42%	+0.31 pp	$1,589
30Y	-84.11%	-5.95%	-84.42%	+0.31 pp	$1,589

Risk & Highlights

Best Year+31.30%2025

Worst Year-83.64%2023

Max Drawdown-54.46%2025-07-17 → 2026-03-20

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-14.77%	-14.77%	—	+0.41%	-15.2pp
2025	+31.30%	+31.30%	—	+16.64%	+14.7pp
2024	-4.20%	-4.20%	—	+24.00%	-28.2pp
2023	-83.64%	-83.64%	—	+24.81%	-108.5pp

MIRA underperformed the S&P 500 by 41.26pp over the past year (-12.82% vs +28.44%).

Loading summary...

MIRA Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
MIRAMIRA Pharmaceuticals, Inc.	$40M	-7.4%	-31.5%	-12.8%	—	-84.1%	-84.1%	-84.1%
ATAIAtai Beckley N.V	$1.0B	+8.3%	+3.4%	+172.1%	—	+99.0%	-79.9%	-47.8%
CMPSCOMPASS Pathways plc	$938M	+69.7%	+42.3%	+130.7%	—	+15.9%	-73.3%	-67.9%
MNMDMind Medicine (MindMed) Inc.	$2.0B	—	+51.7%	+215.9%	—	+506.7%	-58.8%	+512.1%
CYBNCybin Inc.	$304M	—	-26.4%	-6.3%	—	-49.9%	-90.2%	-99.7%
NRXPNRx Pharmaceuticals, Inc.	$84M	+35.6%	+16.0%	+49.8%	—	-50.3%	-99.0%	-96.8%
SILOSilo Pharma, Inc.	$2M	+18.3%	+34.2%	-39.2%	—	-79.5%	+80.4%	+28.9%
LPCNLipocine Inc.	$13M	+27.2%	-70.9%	-31.9%	—	-43.6%	-90.1%	-98.5%
PSTVPlus Therapeutics, Inc.	$15M	+80.2%	-55.2%	-59.9%	—	-93.8%	-99.3%	-100.0%
ENVBEnveric Biosciences, Inc.	$133,267	+59.8%	-5.2%	-77.5%	—	-99.1%	-100.0%	-100.0%
JAZZJazz Pharmaceuticals plc	$14.3B	+22.3%	+22.6%	+79.6%	—	+52.3%	+24.3%	+45.6%

Compare:MIRA vs ATAI MIRA vs CMPS MIRA vs MNMD MIRA vs ATAI vs CMPS

About MIRA Dividend Returns

MIRA Pharmaceuticals, Inc. (MIRA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of MIRA over the past year?

MIRA Pharmaceuticals, Inc. (MIRA) delivered a return of -12.82% over the past year. Since MIRA does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in MIRA be worth today?

A $10,000 investment in MIRA Pharmaceuticals, Inc. one year ago would be worth $8,718 today, representing a loss of $1,282.

Q3Does MIRA pay dividends?

MIRA Pharmaceuticals, Inc. (MIRA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For MIRA, the total return equals the price-only return.

Q4Did MIRA beat the S&P 500?

No, MIRA Pharmaceuticals, Inc. (MIRA) underperformed the S&P 500 by 41.26 percentage points over the past year. MIRA delivered a total return of -12.82%, compared to the S&P 500's 28.44%. This means a passive S&P 500 index fund outperformed MIRA by 41.26pp during this period.

Q5What is MIRA's worst drawdown?

MIRA Pharmaceuticals, Inc. (MIRA) experienced a maximum drawdown of -54.46% over the past year, declining from its peak on 2025-07-17 to its trough on 2026-03-20. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is MIRA's long-term total return over 10, 20, or 30 years?

Here are MIRA Pharmaceuticals, Inc. (MIRA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -84.1% (-16.8% CAGR) — $10,000 would have grown to $1,589. Over 20 years: -84.1% total return (-8.8% CAGR) — $10,000 → $1,589. Over 30 years: -84.1% total return (-5.9% CAGR) — $10,000 → $1,589. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was MIRA's best and worst year?

MIRA Pharmaceuticals, Inc.'s best calendar year was 2025 with a total return of 31.3%. Its worst year was 2023 with a total return of -83.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 114.9 percentage points.